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Abstract: Toll-like receptors (TLRs) have been
identified as a major class of pattern-recognition
receptors. Recognition of pathogen-associated mo-
lecular patterns (PAMPs) by TLRs, alone or in
heterodimerization with other TLR or non-TLR
receptors, induces signals responsible for the acti-
vation of genes important for an effective host
defense, especially proinflammatory cytokines. Al-
though a certain degree of redundancy exists be-
tween signals induced by the various TLRs, recent
studies have identified intracellular pathways spe-
cific for individual TLRs. This leads to the release
of cytokine profiles specific for particular PAMPs,
and thus, TLRs confer a certain degree of specific-
ity to the innate-immune response. In addition to
the activation of the innate-immune response,
TLR-mediated recognition represents a link be-
tween the innate- and acquired-immune systems,
by inducing the maturation of dendritic cells and
directing the T helper responses. Alternatively, re-
cent data have also suggested TLR-mediated es-
cape mechanisms used by certain pathogenic mi-
croorganisms, especially through TLR2 induction
of anti-inflammatory cytokines. Finally, the crucial
role of TLRs for the host defense against infections
has been strengthened recently by the description
of patients partially defective in the TLR-activation
pathways. J. Leukoc. Biol. 75: 749–755; 2004.
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THE INNATE-IMMUNE RESPONSE AND TOLL-
LIKE RECEPTORS (TLRs)
The host defense against pathogenic microorganisms comprises
innate and acquired immunity. These two relatively distinct
sets of responses are sequentially activated during the infection
and ultimately ensure the elimination of the microbial patho-
gen. Whereas the innate-immune system is activated within
minutes after the invasion of the host and is responsible for the
defense during the initial hours and days of the infection,
acquired immunity requires at least 7–10 days before a proper
cellular or humoral response occurs. Although the innate-
immune system, comprising both cellular [e.g., monocytes,
neutrophils, natural killer (NK) cell] and humoral (e.g., com-
plement, lysozyme) components, is very effective in dealing
with the vast majority of the infections, it has been long
believed to be nonspecific to the invading pathogen. The
secondary activation of specific acquired immunity mediated
by T- and B-lymphocytes would overcome this shortcoming and
eliminate the pathogen. Although this scenario is correct to a
certain extent, the dogma of the nonspecific nature of the
innate-immune responses has been recently challenged by the
discovery of a novel class of receptors, the TLRs, which have
been proven to be crucial for recognition of microbes by the
innate-immune system and for bridging the innate- and ac-
quired-immune responses.
Toll has been first described initially as a type I transmem-
brane receptor, with an important role in the dorso-ventral
development of the Drosophila embryo [1]. In addition to that,
it had become apparent that the absence of Toll in genetically
deficient Drosophila also results in a severely impaired defense
against fungi and Gram-positive bacteria [1]. Whereas the
extracellular domain of Toll contains leucine-rich repeats, the
intracellular tail of the receptor was shown to display a striking
homology with the intracellular domain of the interleukin-1
receptor (IL-1R) type I, being designated as the Toll/IL-1R
(TIR) domain. The initial data suggested that Toll is an
important component of Drosophila antimicrobial defense and
that mammalian homologues might have similar functions.
Indeed, 10 different mammalian TLRs have been identified in
humans [2].
During the last few years, extensive research in this field has
identified TLRs as a major class of signaling receptors, recog-
nizing conserved bacterial structures called pathogen-associ-
ated molecular patterns (PAMPs) [3, 4]. The specificity of TLR
recognition for several important PAMPs has been identified,
including recognition of peptidoglycan (PGN), bacterial li-
poproteins, and zymosan by TLR2; double-stranded RNA by
TLR3; lipopolysaccharide (LPS) and heat-shock proteins
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(HSPs) by TLR4; flagellin by TLR5; and CpG motifs of bacte-
rial DNA by TLR9 [5]. A multitude of studies have reported
additional microbial ligands for TLRs, as summarized in other
reviews [2, 5]. In addition, an increasing number of reports
suggest recognition of endogenous ligands such as HSPs, fi-
bronectin, and hyaluronic acid oligosaccharides by TLRs and
modulation of autoimmune processes [6]. The scope of the
present review is to focus on the consequences of TLR micro-
bial interaction for the host defense against infections and to
review the mechanisms activated by TLRs during infections
with live microorganisms.
SPECIFICITY OF MICROBIAL RECOGNITION
THROUGH TLRs
Despite the supposed nonspecificity of the innate-immune
response, it has long been known that cytokine release upon
stimulation with Gram-positive or Gram-negative bacteria
shows important quantitative and qualitative differences [7–9].
This phenomenon now has been explained by the demonstra-
tion of the recognition of PGN and LPS, the main components
of Gram-positive and Gram-negative bacteria by TLR2 and
TLR4, respectively [10]. The TLR–PAMP interaction results in
the recruitment of specific adaptor molecules such as MyD88
and Mal, which then bind the IL-1R-associated kinase (IRAK).
The signal is thereafter transmitted through a chain of signaling
molecules, which is apparently common to all TLRs, involving
the tumor necrosis factor (TNF) receptor-associated factor-6
(TRAF6) and mitogen-activated protein kinases [11]. Thereaf-
ter, activation of nuclear factor (NF)-B and activated pro-
tein-1 (AP-1) leads to transcription of genes involved in the
activation of the innate host defense, notably proinflammatory
cytokines (Fig. 1).
Ligation of TLR4 or TLR3 recruits an additional adaptor
molecule called TIR domain-containing, adapter-inducing in-
terferon- (IFN-; TRIF) [12, 13]. In addition to potentiating
the secretion of the proinflammatory cytokines, TRIF mediates
unique signals leading to secretion of IFN- and indirect
up-regulation of IFN-dependent genes such as IFN-inducible
protein 10 (IP-10) and inducible nitric oxide synthase (iNOS;
Fig. 2). Moreover, a recent study described TRAM as an
adaptor molecule specifically recruited to TLR4 [14]. Concep-
tually, it is likely that recruitment of specific adaptor mole-
cules, such as TRIF and TRAM, confers specificity to the
response activated by a certain TLR and therefore as a conse-
quence of recognition of a particular PAMP. Our recent finding
that NOD2, an intracellular molecule involved in the patho-
genesis of Crohn’s disease, specifically mediates cytokine in-
duction by TLR2 but not TLR4 agonists indicates that it may
be part of a TLR2-specific pathway [15] (Fig. 2). It is to be
expected that more adaptor molecules conferring specificity to
the intracellular pathways induced by the various TLRs will be
described in the near future.
Large receptor complexes, which are formed among various
TLRs or TLR and non-TLR moieties, confer a further degree of
specificity. In this way, heterodimers of TLR2/TLR1 recognize
triacetylated bacterial lipopeptides, whereas TLR2/TLR6 het-
erodimeres recognize diacetylated Mycoplasma lipopeptides
[16], and similar heterodimerization is likely to occur for other
PAMPs. As mentioned, several non-TLR receptor chains co-
operate with TLRs for the recognition of PAMPs; examples are
CD14 and CD11b/CD18 for recognition of LPS by TLR4 [17],
CD14 for recognition of lipoteichoic acid by TLR4 [18], and
dectin-1 for recognition of zymosan and Candida albicans by
TLR2 [19, 20].
The resulting model for the recognition of PAMPs by TLRs
is one in which a variety microbial pathogens, each containing
several different PAMPs, interacts with a certain combination
of TLR (and non-TLR) receptors on the cell membrane of the
host cells. As the various TLRs or TLR complexes will trigger
specific intracellular pathways, the signal resulting from the
activation of a specific combination of TLRs will induce a
response best suited for the invading pathogen.
Fig. 1. The common pathway of intracellular signaling by
IL-1R and TLRs. After the discovery of the human homo-
logues of Drosophilla Toll, it had become apparent that
intracellular domains of IL-1R type I and TLRs share a
high degree of homology; they recruit identical adaptor
molecules including MyD88 and IRAK and induce similar
intracellular pathways leading to activation of nuclear fac-
tors NF-B and AP-1 (with permission from ref. [11]).
IL-1RacP, IL-1R accessory protein; TAK1, transforming
growth factor--activated kinase 1; IKK, inhibitor of B
kinase.
750 Journal of Leukocyte Biology Volume 75, May 2004 http://www.jleukbio.org
THE ROLE OF TLRs DURING INFECTION
WITH LIVE MICROORGANISMS
In vitro studies strongly suggest that TLRs have a crucial role
in the recognition of microbial pathogens and that signals
mediated by TLRs are crucial for mounting an effective host
defense. Several in vivo studies have investigated the role of
the adaptor molecules MyD88 and IRAK4 in infections with
live microorganisms as an initial screening for a role of TLRs
in experimental models of infection. MyD88 is essential for the
stimulation of proinflammatory cytokines such as TNF, IL-1,
IL-12, or IL-6, virtually by the entire range of TLR agonists.
Based on these observations, it has been hypothesized that
MyD88/ mice would be highly susceptible for infections
with Gram-negative and Gram-positive microorganisms. In-
deed, MyD88 is essential to host defense against Gram-positive
bacteria such as Staphylococcus aureus [21] and Listeria mono-
cytogenes [22] but also Mycobaterium avium [23] and parasites
such as Toxoplasma gondii [24], Leishmania major [25], and
the intestinal nematode Trichuris muris [26]. The protective
mechanisms triggered through MyD88 mainly include release
of proinflammatory cytokines and of reactive nitrogen and
oxygen intermediates [22, 24]. It is interesting that the phago-
cytic capacity of MyD88/ cells remains intact [27]. In
contrast with the microorganisms mentioned, Mycobacterium
tuberculosis elicits host defense through largely MyD88-inde-
pendent pathways [28], and prion pathogenesis is completely
MyD88-independent [29]. No data about Gram-negative infec-
tion in MyD88/ mice are available.
A similar phenotype is found in IRAK4/ mice, which are
deficient in cytokine production, resistant to endotoxic shock
but highly susceptible to S. aureus infection [30]. IRAK4/
mice display increased susceptibility to lymphocytic chorio-
meningitic virus infection, likely as a result of defective IFN-
production [30].
TLR2 is the major receptor for PAMPs of Gram-positive
bacteria, such as PGN and lipoteichoic acids [5], and TLR2
has been hypothesized to have a central role in the host defense
against these microorganisms. Indeed, TLR2/ mice are
highly susceptible to infection with S. aureus [21, 31], Strep-
tococcus pneumoniae [32, 33], M. tuberculosis, or Mycobacte-
rium bovis [34, 35], but the mechanisms of protection induced
by TLR2 ligation are unclear and seem to differ in the different
infections. Defective cytokine stimulation in TLR2/ mice
has been implicated in infections with S. aureus and M. tuber-
culosis [32, 34], whereas increased levels of inflammation
(despite similar cytokine levels) have been incriminated in
experimental, pneumococcal infections [33]. TLR2 also medi-
ates host defense against T. gondii by mediating cytokine and
NO release [36].
The most intensively studied TLR deficiency is that of
TLR4, partly as a result of the availability of the natural
TLR4-defective mutants, C3H/HeJ and ScCr mice. Even be-
fore the molecular nature of the LPS hyporesponsiveness in
C3H/HeJ mice was discovered, it was known that C3H/HeJ
mice are more susceptible to Gram-negative infections such as
Neisseria meningitidis meningitis and Escherichia coli urinary
tract infection [37, 38]. These earlier observations were con-
firmed later [39, 40] and were extended by the demonstration
of increased susceptibility to Gram-negative infections such as
Haemophilus influenzae pneumonia [41], Salmonella peritonitis
and Klebsiella pneumoniae sepsis [42, 43] but also Gram-
positive infections such as S. pneumoniae pneumonia [44]. In
addition, TLR4 mediates recognition of the fungal pathogens
Aspergillus fumigatus [45–47] and C. albicans [48, 49], and the
host defense against the latter was impaired in TLR4-deficient
mice [48]. A crucial defect in these infection models in
TLR4/ mice is the decreased neutrophil recruitment to the
site of infection [39, 41, 48], which is a result of defective
production of chemokines [41, 48] and decreased expression of
chemokine receptors [50]. Host defense against M. tuberculosis
is only marginally affected in TLR4/ mice [34]. TLR4 is
not involved in the host defense against experimental Legio-
nella pneumoniae [51] or influenza virus infection [52], but
Fig. 2. Differential TLR-mediated pathways can bring
specificity to innate immunity. In addition to the common
MyD88 pathway, TLRs can also recruit specific adaptor
molecules and activate differential intracellular pathways:
Ligation of TLR4 recruits TRIF and transverse rectus
abdominis musculocutaneous (TRAM), mediating unique
signals leading to secretion of IFN- and indirect up-
regulation of IFN-dependent genes such as IP-10 and
iNOS. We have also recently shown that nonobese diabetic
(NOD)2, an intracellular molecule, specifically mediates
cytokine induction by TLR2 but not TLR4 agonists, indi-
cating that it may be part of a TLR2-specific pathway.
TIRAP, TIR domain-containing adapter protein; MD-2,
myeloid differentiation protein-2.
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TLR4-deficient mice have an impaired resistance against re-
spiratory syncitial virus as a result of defective IL-12 release
and NK-cell function [52, 53].
TLRs: THE BRIDGE BETWEEN INNATE AND
ACQUIRED IMMUNITY
When the innate host defense mechanisms fail to eliminate the
pathogenic microorganisms during the first days of an infec-
tion, the host will mount an additional immune response
adapted specifically to the particular invading bacteria. This
acquired-immune response is mediated by clonal expansion of
T cell and B cell populations able to interact specifically with
particular microorganisms. By enhancing microbicidal mech-
anisms of the cells of the innate-immune system, finally the
pathogen is being eliminated. These processes are mediated by
presentation of pathogen-derived peptides by professional an-
tigen-presenting cells (APC) to T cells. Dendritic cells (DC) are
the most effective APC, which function as sentinel at the
frontline of host defense in tissues such as skin and mucosa
and bridge the innate and acquired immunity [54]. Stimulation
of immature DC by microbial stimuli induces production of
proinflammatory cytokines such as TNF and IL-12, which can
induce differentiation of T cells into T helper cell type 1 (Th1)
cells. In addition, these stimuli induce up-regulation of co-
stimulatory molecules such as CD40, CD80, and CD86 [54].
This process is called DC maturation, and it strongly potenti-
ates the ability of DC to activate naive T cells. DC migrate to
the lymphoid organs, where presentation of antigen and T cell
proliferation finally take place [55].
It has become apparent that TLRs play a crucial role in
these processes, and they form the bridge between the micro-
bial recognition by the innate-immune system, DC maturation,
and T cell proliferation [56]. Subsets of human DC express
TLRs on their surface, which respond differently to microbial
antigens [57]. A variety of microbial PAMPs are able to induce
cytokine release and DC maturation: LPS through TLR4, CpG
through TLR9, bacterial lipopeptides through TLR2 [56, 58].
The stimulation of specific TLRs results in the release of IL-10
or IL-12, leading to skewing of the T cell response toward Th1
or Th2 cytokines [59]. Thus, TLR2-mediated signals seem to
preferentially induce a Th2 profile, whereas TLR4 activation
mainly leads to a Th1 response [60]. In addition, release of
IL-6 by DC relieves the suppression of effector T cells by
regulatory T cells [61]. Thus, through specific TLR stimulation,
DC can process the information leading to the polarization of
the acquired-immune response.
It has also been demonstrated that at least two distinct,
intracellular signaling pathways regulate DC maturation by
different TLRs: One pathway induced mainly by TLR9 is
strictly dependent on MyD88, whereas another pathway
induced primarily by TLR4 can induce DC maturation
through a MyD88-independent mechanism [56]. It has been
suggested that these two pathways converge at the level of
TRAF6 [62].
THE USE OF TLRs AS ESCAPE MECHANISM
FROM HOST DEFENSE
An aspect of TLR biology, which has only recently become
apparent, is the hijacking of the TLR signaling by certain
pathogens to evade the recognition and elimination by the
immune system. Several studies to date suggest that TLR2-
dependent mechanisms induced by certain microorganisms
contribute to evasion or inhibition of the immune response.
These effects on host defense are based on the initial obser-
vation that TLR2-induced signals in DC preferentially induce
a Th2 cytokine pattern [60], which is known to have down-
modulatory activity on cellular immunity. Subsequently, it was
demonstrated that the M. tuberculosis 19-kD protein inhibits
IFN--regulated human leukocyte antigen-DR and Fc receptor
for immunoglobulin G-1 expression on human macrophages
through TLR2-dependent mechanisms [63]. The results of
these in vitro studies were corroborated by similar data in in
vivo experimental infections. Yersinia enterocolitica and C.
albicans have been shown to exploit TLR2-mediated IL-10
release to induce immunosuppression [64, 65]. In the case of
Candida infection, this effect is attained through generation of
CD4CD25 regulatory cells [65]. Lack of TLR2 in knockout
mice renders them more resistant to lethal Yersinia and Can-
dida infections [64, 65]. Similarly, A. fumigatus also evades
immune recognition during germination through TLR2-medi-
ated IL-10 production, whereas proinflammatory TLR4-medi-
ated signals are lost [47]. Another example of deleterious TLR2
activation is that of mycobacteria and human immunodefi-
ciency virus type 1 (HIV-1) coinfection, in which HIV-1 ex-
pression is induced by mycobateria through TLR2 signaling
[66]. All these data suggest that several microorganisms,
among which the fungal pathogens C. albicans and A. fumiga-
tus are prominent, use TLR2-mediated induction of anti-in-
flammatory cytokines to down-modulate the microbicidal func-
tions of leukocytes and evade the host defense (Fig. 3).
TLRs IN HUMAN INFECTIOUS DISEASES
Given the results in experimental infections, one might assume
that TLRs have a crucial role of these receptors in human
diseases as well. Several lines of evidence have confirmed this
assumption. Infusion of endotoxin into human volunteers mod-
ulates the expression of TLRs in humans [67]. A higher ex-
pression of TLR2 and TLR1, known to mediate cell activation
by lipoproteins from Mycobacterium leprae, has been found in
patients with localized tuberculoid lepra, whereas these recep-
tors were far less expressed in those with disseminated lepro-
matous disease [68]. A polymorphism of TLR2 gene
(Arg677Trp), which is unable to mediate mycobacterial signal-
ing [69], has also been associated with lepromatous leprosy
[70]. These data suggest that the intensity of the immune
response to this pathogen is proportional to the expression of
TLR2 and TLR1. This hypothesis is also in line with the
description of hyporesponsiveness to vaccination with Borrelia
burgdorferi outer-surface lipoprotein in humans with decreased
cell-surface expression of TLR1 [71].
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The role of a TLR4 polymorphism, the Asp299Gly mutation,
on the susceptibility to infections is controversial. Whereas
some studies have suggested an increased susceptibility to
Gram-negative infections or Gram-negative septic shock [72,
73], others have been unable to find a role of this polymor-
phism in meningococcal disease [74], polymicrobial sepsis
[75], and urogenital tract Candida and Chlamydia infection
[76, 77]. Controversy also surrounds the functional conse-
quences of this mutation: Whereas initial studies suggested
hyporesponsiveness to LPS in individuals bearing this muta-
tion [78], recent studies have failed to confirm this [79, 80]. We
have also been unable to find a defective cytokine production
in cells from volunteers bearing the Asp299Gly polymorphism
after stimulation with exogenous (E. coli LPS, N. meningitidis
LPS, A. fumigatus, Cryptococcus neoformans) and endogenous
(human recombinant HSP-60) TLR4 ligands (C. van der Graaf,
submitted). Another TLR2 polymorphism, the Arg753Gln mu-
tation, has been found in two patients with Staphylococcal
sepsis [81], but no studies have been published to confirm the
role of this polymorphism.
Probably the most solid proof of the central role of TLR-
mediated signals in human infections has been provided re-
cently by the description of recurrent bacterial infections,
especially caused by pyogenic bacteria, in patients with
IRAK-4 deficiency [82, 83]. This deficiency resulted in defec-
tive response to LPS, IL-1, and IL-18 in vitro as well as in a
skin blister model of aseptic inflammation [83]. As these
patients do not exhibit other infections, it is likely that IRAK-
4-independent pathways induce alternative, protective signals.
Other partial defects in the TLR pathways are likely to be
found in the next few years. However, a complete deficiency of
one of the major TLR pathways is unlikely to be found, as it is
probably not compatible with survival.
CONCLUSIONS AND FUTURE DIRECTIONS
The results of in vitro experiments as well as of in vivo
infection models and from various groups of patients provide
support for the notion that TLRs are a major class of pathogen-
recognition receptors: they recognize PAMPs from the various
classes of the microorganisms, leading to production of cyto-
kines and activation of the microbicidal mechanisms of leuko-
cytes; they induce maturation of DC and activate them, thereby
providing a bridge between innate and acquired immunity; and
they modulate the function of T regulatory cells. In addition,
initial data on the differential pathways induced intracellularly
by the different TLRs, such as the recruitment of TRIF by
TLR3 and TLR4, suggest a specificity of the signals triggered
by the various TLRs. As the gene-transcription profile of
various TLR agonists, as measured by microarray techniques,
exhibits a relatively high degree of redundancy between dif-
ferent TLRs, this raises the question of how extended this
specificity is. Finally, an emerging field of investigation not
addressed in this review is that of TLR recognition of endog-
enous ligands and the role of these receptors in noninfectious
and autoimmune inflammatory processes.
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